Passage Bio, Inc. (PASG) Tops Q2 EPS by 3c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.44), $0.03 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Morgan Stanley Upgrades Coal India Ltd (COAL:IN) to Overweight
• BofA Securities Starts PhysicsWallah Ltd (PWL:IN) at Underperform